New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol

Overview of attention for article published in Drug Design, Development and Therapy, October 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Umeclidinium plus vilanterol versus fluticasone propionate plus salmeterol for chronic obstructive pulmonary disease: a meta-analysis of randomized, controlled trials

Article in Postgraduate Medical Journal (April 2024)

Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study

Article in International Journal of Chronic Obstructive Pulmonary Disease (May 2023)

Development and validation of a bioanalytical method for the quantification of CHF6550 and its metabolite (CHF6671) in rat plasma and lung homogenate using LC–MS/MS

Article in Journal of Chromatography B (March 2023)